|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 October 2017 |
|
Main ID: |
NCT02492451 |
|
Date of registration:
|
18/06/2015 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Endometrial Injury Versus Luteal Phase Support in Intrauterine Insemination Cycles
|
|
Scientific title:
|
Endometrial Injury Versus Luteal Phase Support in Intrauterine Insemination Cycles |
|
Date of first enrolment:
|
June 2015 |
|
Target sample size:
|
118 |
|
Recruitment status: |
Terminated |
|
URL:
|
https://clinicaltrials.gov/show/NCT02492451 |
|
Study type:
|
Interventional |
|
Study design:
|
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Turkey
| | | | | | | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Patients are undergone intrauterine insemination with gonadotropin stimulation
- Bilateral patent fallopian tubes revealed by hysterosalpingography or laparoscopy
- After semen preparation for intrauterine insemination, total progressive sperm count >
5 million
Exclusion Criteria:
- endocrin or metabolic disorders,
- uterine factor,
- pelvic inflammatory disease,
- women with basal follicle-stimulating hormone (FSH) level >15 IU/mL,
- body mass index (BMI) = 35 kg/m2,
- age = 40 and < 18 years,
Age minimum:
18 Years
Age maximum:
40 Years
Gender:
Female
|
|
Health Condition(s) or Problem(s) studied
|
|
Pregnancy
|
|
Intervention(s)
|
|
Drug: progesterone (Crinone® %8 vaginal progesterone gel)
|
|
Other: Endometrial Injury
|
|
Primary Outcome(s)
|
|
Pregnancy Rate
[Time Frame: 12 weeks]
|
|
Secondary ID(s)
|
|
zeynepkamil
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|